AVRANTERIS TECHNOLOGIES GLOBAL CORP.
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 12 Aug 2026, 18:31 | Results for the Second Quarter of 2026 | Periodic Reports | MS | 03014 | |
| 12 Aug 2026, 18:25 | Quarterly Results Announcement and SEC Form 10-Q | Periodic Reports | MS | 03014 | |
| 6 Aug 2026, 02:42 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 4 Aug 2026, 04:23 | Court Orders Granted | Company Administration | MS | 09014, 12008 | |
| 4 Aug 2026, 00:04 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 31 July 2026, 21:36 | Application for quotation of securities - AVR | Other | — | 06020 | |
| 31 July 2026, 21:24 | Cleansing Notice | Securities Administration | — | 06018 | |
| 31 July 2026, 21:24 | Cleansing Notice | Securities Administration | — | 06018 | |
| 31 July 2026, 20:59 | Cleansing Notice Update | Company Administration | — | 12008 | |
| 31 July 2026, 20:09 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 31 July 2026, 19:59 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 23 July 2026, 22:27 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 15 July 2026, 19:18 | Application for quotation of securities - AVR | Other | — | 06020 | |
| 14 July 2026, 19:11 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 3 July 2026, 20:18 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 2 July 2026, 18:53 | Form S-3 Registration Statement | Securities Administration | — | 06010 | |
| 1 July 2026, 21:44 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 25 June 2026, 02:35 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 25 June 2026, 02:30 | Application for quotation of securities - AVR | Other | — | 06020 | |
| 22 June 2026, 19:47 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 9 June 2026, 18:31 | PARADIGM - French Regulatory Clearance | Company Update | — | 11001 | |
| 5 June 2026, 21:45 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 5 June 2026, 21:43 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 3 June 2026, 04:04 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 25 May 2026, 18:53 | Prospectus Supplement and Sales Agreement | Securities Administration | MS | 06009 | |
| 19 May 2026, 00:58 | Initial Director's Interest Notice x 2 | Director Interests | — | 02008 | |
| 13 May 2026, 19:50 | Board Appointments | Company Administration | — | 12001 | |
| 13 May 2026, 18:30 | Results for the First Quarter of 2026 | Periodic Reports | MS | 03014 | |
| 13 May 2026, 18:22 | Quarterly Results Announcement and SEC Form 10-Q | Periodic Reports | MS | 03014 | |
| 6 May 2026, 19:04 | First US Patients Treated in Global Pivotal PARADIGM Trial | Company Update | MS | 11001 | |
| 5 May 2026, 21:55 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 30 Apr 2026, 19:31 | Termination of a Material Definitive Agreement | Company Update | — | 11001 | |
| 30 Apr 2026, 02:50 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 30 Apr 2026, 02:48 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 29 Apr 2026, 02:32 | CMS Reimbursement Secured for PARADIGM Trial | Company Update | MS | 11001 | |
| 28 Apr 2026, 00:58 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 24 Apr 2026, 19:12 | Entry into a Material Definitive Agreement | Company Update | — | 11001 | |
| 15 Apr 2026, 00:43 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 13 Apr 2026, 22:37 | Application for quotation of securities - AVR | Other | — | 06020 | |
| 8 Apr 2026, 01:26 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 2 Apr 2026, 06:13 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 12 Mar 2026, 23:56 | Notification regarding unquoted securities - AVR | Other | — | 06021 | |
| 5 Mar 2026, 22:09 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 4 Mar 2026, 21:07 | Notification of cessation of securities - AVR | Other | — | 06027 | |
| 27 Feb 2026, 20:46 | Corporate Governance Statement and Appendix 4G | Company Administration | — | 03024, 03025 | |
| 27 Feb 2026, 20:31 | 2025 Financial Results and Corporate Update | Financial Results | MS | 03003, 03014 | |
| 27 Feb 2026, 20:19 | Annual Report to shareholders | Financial Results | MS | 03001, 03003, 03011 | |
| 26 Feb 2026, 05:13 | Underwritten Offering - End of Stabilisation Period | Securities Administration | — | 06009 | |
| 6 Feb 2026, 04:42 | Statement of CDIs on issue - AVR | Securities Administration | — | 06007 | |
| 4 Feb 2026, 05:43 | Notification of cessation of securities - AVR | Other | — | 06027 |
1–50 of 119
1 / 3